The AABB Assessment Process
A different kind of visitor, on a different kind of clock
BPD-0512 is filed. The 483 response is sitting with FDA. And now a third thing lands on your calendar, one that’s been “on the calendar” in the loosest sense for months and is suddenly real: Lakeshore’s AABB (Association for the Advancement of Blood & Biotherapies) reassessment cycle has opened.
Nobody showed up unannounced. Your Quality Analyst (QA) logs into APEX — AABB’s own online accreditation portal, the system Lakeshore uses to do business with AABB directly — and starts working through AABB’s self-assessment tool, activity by activity: donor collection, testing, component processing, labeling, distribution, equipment, the works. This is the self-assessment phase, and it’s Lakeshore’s own staff, not an outside reviewer, doing the looking.
She’s most of the way through the equipment section when she stops. The self-assessment tool asks, in its own words, whether Lakeshore can produce documented evidence that every piece of laboratory equipment currently in service has been reviewed and justified as fit for its intended use. She already knows the answer, because DI-0301 — her own data-integrity self-assessment, built for a completely different reason — already found it: LAB-07, the legacy benchtop analyzer, passes every quality-control (QC) check it runs, every morning, without exception. What it doesn’t have is a dated, signed document saying, on the record, that someone with the authority to make that call has reviewed it and confirmed it’s still fit for its job.
She brings it to you, and so does the deferred-donor-record cadence question — still sitting exactly where data-integrity-and-records left it, “under internal review,” neither closed nor forgotten. You notice something, and so does she: neither finding is a surprise. AABB’s own self-assessment tool just independently rediscovered a gap Lakeshore already knew about and was already working. That’s not luck. That’s what a good internal self-assessment is supposed to buy you — and this module is about to make the case for exactly why.
No citations yet. Just APEX, a self-assessment tool working through Lakeshore’s own activities one by one, and the honest question of what happens next, once the on-site assessor actually walks in.
Why this rule exists — and the ITSM bridge
Here’s the failure AABB’s whole process is built to catch, and it’s a close cousin of the one FDA’s inspection authority catches, not an identical twin. A blood establishment can write a flawless set of policies, processes, and procedures (PPPs) — the internal documents that spell out exactly how Lakeshore does its own regulated work — and still not actually follow a single one of them on the floor. A self-reported “yes, we have a policy for that” isn’t verification any more than a vendor’s own claim that its system is “fully compliant” is verification. Someone without a stake in the answer has to actually look.
You already navigate this exact shape of problem in IT, just under a different name. ISO 20000 (IT service management), ISO 27001 (information security management), and SOC 2 (a third-party assurance report on security and availability controls) are all voluntary certifications: nobody is legally required to hold any of them. An external auditor checks your organization’s own documented processes against a standard you chose to adopt, and “failing” means losing or risking the certification — which matters commercially, sometimes enormously, because customers write it into contracts, but it isn’t itself a legal violation the way failing a mandatory regulatory audit is. AABB accreditation is that exact same shape, built for blood banking specifically. And you already know a concrete downstream consumer of that distinction: Riverside General Hospital, Lakeshore’s own established hospital customer, is precisely the kind of counterparty that may require AABB accreditation as a condition of doing business — a contractual expectation, not a federal one.
Here’s where this module earns its keep: FDA inspection and AABB assessment look, from across the room, like the same kind of visit. They are not the same instrument, and confusing them is exactly the mistake a Director can’t afford to make.
The rule in plain English
The two-phase structure. AABB’s own accreditation process runs in two phases: the self-assessment phase, then the on-site assessment phase. Self-assessment comes first, performed in APEX, AABB’s own online accreditation portal — Lakeshore’s staff work through AABB’s own tool, naming every activity Lakeshore performs and documenting, activity by activity, how its own PPPs address AABB’s Standards. AABB reviews and approves that self-assessment before the on-site phase is allowed to proceed. Only after the on-site assessment is successfully completed — including the resolution of any nonconformances the assessor identifies — does Lakeshore actually achieve (or, in Lakeshore’s case this cycle, retain) AABB accreditation. Once a facility is accredited, that on-site phase repeats on a fixed two-year cycle — which is exactly why this is happening now, not because anything went wrong.
One more piece of context worth naming, even though it doesn’t directly apply to Lakeshore’s own situation this cycle: a facility seeking AABB accreditation for the very first time (or adding a brand-new activity it’s never been accredited for) has to have a minimum of six months of actual operating history in that activity before the process can even begin. Lakeshore isn’t in that position — it’s already accredited and going through its routine reassessment — but it’s worth knowing the full shape of the process, not just the slice that applies to you this time.
What “AABB assessment” is checking, and what “FDA inspection” is checking, are genuinely different things. They overlap in subject matter — the same quality system, the same records, sometimes the same piece of equipment — but they differ in almost every other way that matters:
| FDA inspection | AABB assessment | |
|---|---|---|
| Voluntary or mandatory? | Mandatory. Backed by federal statute — 21 U.S.C. 374, the same inspection authority module 1 covered — government-run. | Voluntary. Industry-run. Lakeshore chose to seek and keep this accreditation; nothing forces it to. |
| Checked against what? | Facility, records, and practice checked against binding federal regulation — 21 CFR Parts 211, 600-series, 606, 610, 630, Part 11, and more. | Lakeshore’s own PPPs checked against AABB’s own Standards — and then, just as importantly, checked against whether those PPPs are actually followed. |
| What does “failing” mean? | A Form 483, potentially escalating to a Warning Letter, potentially landing at OAI (Official Action Indicated) — a federal regulatory action with real legal weight. | A nonconformance that blocks accreditation from being renewed until it’s resolved — a serious hit to Lakeshore’s standing, but not itself a federal legal action. |
| Legal character | The investigator’s authority to walk in and demand records exists by law, whether Lakeshore likes it or not. | An assessor’s authority to walk in exists only because Lakeshore invited AABB in, as a condition of a credential Lakeshore voluntarily holds. |
Read that last row carefully, because it’s the single most precise, most easily overstated point in this whole module: AABB accreditation is not itself a legal requirement for Lakeshore to operate as a blood establishment. Lakeshore’s actual legal authority to operate — its FDA registration and, where applicable, licensure — is a completely separate thing, already covered in earlier courses in this curriculum, and it doesn’t depend on AABB accreditation at all. What AABB accreditation does carry is serious real-world weight anyway: hospital customers like Riverside General may require it contractually, peers and regulators alike treat it as a credible signal of a functioning quality system, and losing it would be a genuine, painful event for Lakeshore — just not a federal one. Don’t overstate AABB’s authority into something it isn’t, and don’t understate the real consequences of losing it either. Both mistakes are easy to make and both are wrong.
“All standards are addressed in policies, processes and procedures (PPPs), and that PPPs are followed as written” — the sharpest sentence in this whole module. This is AABB’s own stated expectation of what an assessment actually checks for, and it’s a two-part test, not a one-part test. Part one: does a written PPP exist that addresses this AABB Standard? Part two — the part that actually does the work — is the PPP followed, in practice, as written? A policy that exists on paper and a policy that’s actually enforced are two different claims, and this curriculum has already shown you exactly how far apart those two claims can be: data-integrity-and-records found Lakeshore’s own written password-revision policy sitting right next to zero evidence it was ever technically enforced — the policy said passwords would be changed on a schedule, and nobody could produce a log showing it actually happened. That’s the “documented but not implemented” gap this curriculum keeps surfacing, in a new context now. An AABB assessor isn’t trained to be fooled by a well-written binder. The assessor is trained to ask for the binder and the evidence it’s being followed, and treat the second part as the real test.
Citation decoder
Every row below cites sources/aabb/accreditation-process.md, AABB’s own public page describing its accreditation process. This is a new source tier for this curriculum, worth naming precisely: AABB’s own public program description — AABB’s own marketing/informational content about how its accreditation program works, safe to quote directly. It is not AABB Standards text, which stays copyrighted and unquoted everywhere in this curriculum, this module included.
| Citation | How to read it aloud | What it requires | In our scenario |
|---|---|---|---|
| AABB, “Accreditation Process” page, “Accreditation Phases and Expectations” | “AABB’s own accreditation-process page” | AABB’s own public program description. Names the two-phase structure: self-assessment phase, then on-site assessment phase. | The shape of the reassessment cycle Lakeshore just entered. |
| Same page, same section | — | AABB’s own public program description. States AABB’s own expectation: all Standards addressed in PPPs, and PPPs followed as written. | The two-part test — document exists, document is followed — LAB-07’s own gap sits inside. |
| Same page, same section | — | AABB’s own public program description. States the two-year on-site reassessment cycle for an already-accredited facility. | Why this reassessment is happening now, on schedule, not because of a complaint. |
| Same page, same section | — | AABB’s own public program description. States the six-month minimum operating history required before a first accreditation can begin. | Context only — doesn’t apply to Lakeshore’s reassessment, since Lakeshore is already accredited. |
| AABB, “Accreditation Process” page, “Steps to Become AABB-Accredited” | — | AABB’s own public program description. Names APEX as the portal where self-assessment is performed, that AABB reviews and approves it before on-site proceeds, and that accreditation is achieved only upon successful completion of on-site assessment, including resolution of any nonconformances. | What Lakeshore’s QA is doing right now in APEX, and what has to happen before this cycle closes. |
The actual text
From AABB’s own “Accreditation Process” page (AABB’s own public program description), the phases themselves, quoted verbatim:
There are two phases involved with achieving AABB accreditation for the first time or adding a new activity: the self-assessment phase, followed by the on-site assessment phase.
The central expectation — the sentence this module keeps coming back to, quoted verbatim:
The expectations of an AABB assessment are that all standards are addressed in policies, processes and procedures (PPPs), and that PPPs are followed as written.
The reassessment cycle, quoted verbatim:
Once a facility becomes AABB-accredited, it must go through the accreditation process (on-site assessment phase) every two years.
The minimum operating history, named for completeness, quoted verbatim:
Please note that a facility must be in operation for a minimum of 6 months (in the desired accreditation activity) before the initial accreditation process can begin.
And from the same page’s own numbered steps to accreditation, this module’s single most load-bearing phrase, quoted verbatim:
achieve AABB accreditation upon successful completion of the on-site assessment, including resolution of any nonconformances.
AABB’s page also describes, in its own words rather than a single quotable sentence, the steps sitting between those two quotes: Lakeshore performs its self-assessment in APEX (AABB’s online accreditation portal), and AABB reviews and approves that self-assessment before the on-site assessment phase is allowed to proceed. One more detail worth naming briefly, not developing further: AABB’s page also states that a facility can’t advertise any relationship to AABB until it’s actually accredited — a marketing restriction, not something this module needs to go further into.
What an AABB assessor would actually look for
An AABB assessor, on-site at Lakeshore, isn’t checking whether a binder of PPPs exists on a shelf. They’re running the same two-part test AABB’s own page describes, activity by activity, the same discipline DI-0301 already modeled internally.
For LAB-07’s fitness-for-use gap specifically: the assessor would ask to see the written PPP covering legacy-equipment fitness-for-use review — and then ask, separately, to see the dated, signed evidence that review actually happened. That’s a two-part test, procedurally close to, but not identical to, how an FDA investigator would approach the same instrument. An FDA investigator checks LAB-07 against the binding four-part legacy-system test from FDA’s own 2003 Part 11 guidance — a federal compliance question. An AABB assessor checks the same instrument against Lakeshore’s own PPP for equipment qualification — a PPP-versus-practice question, under AABB’s own QSE (Quality System Essential) 3, Equipment, the adjacent drawer in AABB’s own Quality System Essentials framework for equipment qualification and fitness-for-use documentation generally (named only, no standard number, consistent with how this curriculum always handles AABB Standards). Same instrument, same underlying gap, two different reviewers asking two related but not identical questions.
For the deferred-donor-record cadence question: the assessor would ask what Lakeshore’s own PPP says about updating the cumulative deferred-donor record, and whether the practice matches it. Lakeshore’s honest answer right now is that the regulatory floor — at least monthly — is being met every cycle, with the dated log to prove it, and that whether to go faster than that floor is a risk question still genuinely under internal review, not yet decided either way. That’s a different kind of answer than a silent gap, and an AABB assessor reading it the way this curriculum has modeled every other honest finding would see an actively-tracked, well-documented open question — not a PPP that says one thing while practice does another. Nothing in AABB’s own equipment or process-control themes requires Lakeshore to move faster than the regulatory floor; this stays a risk decision, not a nonconformance waiting to happen.
For events outside this module’s own subject, named without re-teaching them: an AABB assessor would also want to know about BPD-0512 (the plasma-labeling deviation and recall) and the pending 483 from Lakeshore’s recent FDA inspection, since both are real, relevant quality-system events — not because this module develops either one further, but because a competent assessor doesn’t pretend a known event didn’t happen just because it belongs to a different reviewer’s jurisdiction.
A bad answer, to any of these, sounds like “we have a policy for that.” A good answer produces the policy, and then produces the proof.
Common traps
“We already passed DI-0301’s own internal self-assessment, so the on-site visit is basically a formality.” Not quite — and this is worth refuting precisely, because the instinct behind it is actually half-right. A strong internal self-assessment genuinely does make AABB’s own process more confirmatory than exploratory — that’s exactly the honest point this module exists to make. But AABB’s own page is explicit that accreditation is achieved only upon successful completion of the on-site assessment, including resolution of any nonconformances — the on-site phase is a real, separate gate, not a rubber stamp on top of a good self-assessment. Knowing your own gaps going in is a genuine advantage. It isn’t the same thing as the gate not existing.
“AABB accreditation isn’t legally required, so it doesn’t really matter if Lakeshore loses it.” Wrong, and this is the nuance this whole module is built around. AABB accreditation is not itself a legal requirement to operate — that’s true, and it’s worth saying plainly rather than overstating AABB’s authority. But “not legally required” and “doesn’t matter” are not the same claim. A hospital customer like Riverside General may require AABB accreditation as a condition of doing business, even though federal law itself imposes no such requirement. Losing accreditation could mean losing that contract, and the broader reputational standing that comes with holding it — serious, real consequences, just not legal ones in the way a Warning Letter or an OAI classification would be.
What this means for your job
- Ask your QA what APEX’s self-assessment tool flagged, activity by activity — and whether any of it is new. If DI-0301 already found it, that’s a strength to name explicitly, not a coincidence to shrug past.
- For any gap the self-assessment surfaces, ask for both halves of AABB’s own test: does a written PPP exist, and is there dated evidence it’s actually being followed? Settle for neither half alone.
- Before the on-site assessor arrives, know which open findings you’d disclose proactively — BPD-0512, the pending 483, LAB-07’s criterion-4 gap — the same instinct module 1 taught about a known, actively-worked gap looking like a strength, not a liability, to an outside reviewer.
- Don’t let “not legally required” become the whole sentence when someone asks whether AABB accreditation matters. Finish the sentence: not legally required, and still something Riverside General and other hospital customers may require contractually, with real business consequences if Lakeshore lost it.
- Treat a resolved AABB nonconformance the same way this curriculum treats a well-documented 483 observation — a sign of a functioning quality system, not evidence of one that’s broken, as long as it’s actually resolved on the timeline AABB sets, not quietly left open.
Check your understanding
Wrong, and this is the genuine nuance this module exists to teach — not a simple yes-or-no. She’s right about the first half: AABB accreditation is not itself a legal requirement for Lakeshore to operate as a blood establishment. Lakeshore’s actual legal authority to operate comes from its FDA registration and licensure, a completely separate thing, already covered earlier in this curriculum, and it doesn’t depend on AABB accreditation at all. But “not legally required” doesn’t mean “doesn’t matter.” A hospital customer like Riverside General may require AABB accreditation contractually as a condition of doing business, even though no federal law requires Lakeshore to hold it. Losing accreditation could cost Lakeshore that relationship and real standing in the industry — serious, real-world consequences, just not the kind a court or FDA enforcement action produces.
Related, but not the same thing. An FDA investigator checks LAB-07 against FDA’s own binding four-part legacy-system test from its 2003 Part 11 guidance — a federal compliance question with a 483 or worse riding on a bad answer. An AABB assessor checks LAB-07 against Lakeshore’s own written PPP for equipment fitness-for-use review, and then checks whether that PPP is actually being followed — a PPP-versus-practice question, with an accreditation nonconformance riding on a bad answer instead. Same instrument, same underlying gap (the missing criterion-4 documentation DI-0301 already found), but two different reviewers, checking it against two different things, with two different consequences for failing.
No — and this is worth being precise about, the same way this curriculum has always distinguished a real failure from a well-documented, actively-managed finding. AABB’s own page states accreditation is achieved “upon successful completion of the on-site assessment, including resolution of any nonconformances” — meaning a nonconformance is something Lakeshore resolves as part of completing the process, not automatic proof the process has failed. A known gap, already surfaced honestly by Lakeshore’s own DI-0301 self-assessment, with a corrective action already underway, is exactly the kind of nonconformance this curriculum has modeled before as a sign of a functioning quality system — not a secret an outside reviewer had to dig up.
Where this goes next
Lakeshore’s on-site assessor spends the visit the way the self-assessment tool predicted: PPPs pulled, practice checked against them, activity by activity. The visit surfaces one formal nonconformance — LAB-07’s still-missing criterion-4 fitness-for-use documentation, the same gap DI-0301 already found and was already working. Nothing else rises to that level; the deferred-donor cadence question is discussed, understood, and left exactly where Lakeshore’s own risk judgment has it, under internal review, not treated as a PPP failure. Lakeshore gets a resolution window, submits the dated qualification review the gap has always been missing, and the nonconformance closes. Accreditation continues, on schedule, for another two-year cycle — not because nothing was found, but because what was found was already known, already documented, and resolved on AABB’s own terms.
That resolution requirement — AABB’s own expectation that a nonconformance gets resolved, not just noted — is itself a bridge into this course’s next module. Knowing a PPP exists and is followed as written is only half the job; the other half is having an internal audit program rigorous enough to catch gaps like LAB-07’s before an external assessor ever has to. designing-an-internal-audit-program builds exactly that: auditor independence, risk-based scheduling, real evidence sampling, and a nonconformance grading scale with teeth.